[Pancreatic exocrine secretion in cancer of the pancreas].
Pancreatic exocrine secretion was studied in 22 patients with pancreas cancer. In 17 of patients the diagnosis was made at operation. In all patients examined the pancreocymine-secretin test according to Herfort was performed. The results were compared with those of a control group of 30 healthy subjects. In 95.5 per cent of the examined a statistically significant decreased hydrobicabonate and enzyme secretion was found. The changes in the pancreatic secretion are characterized by the presence of a total secretory deficiency, with a significant diminution ( p less than 0.001) of all parameters of pancreatic secretion.
D002277:Carcinoma / Q000378:metabolism*; D002766:Cholecystokinin; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D012633:Secretin
D012633:Secretin; D002766:Cholecystokinin
Pankreasna ekzokrinna sekretsiia pri bolni s kartsinom na zadstomashnata zhleza.